6 side effects to the new weight loss drug Qsymia

6 Side Effects Of The New Weight Loss Drug Qsymia

July 19, 2012 By RX Recall

Is Qsymia a “magic bullet”?

For years most medical researchers considered weight loss drugs to be vanity products. Researchers now realize that obesity itself is a medical disease that increases a persons chance of serious medical problems such as, diabetes, heart disease and depression. In America, obesity effects 1 out of every 3 persons.

The FDA (Food and Drug Administration) has approved a new weight loss drug called Qsymia, (although the drug will not be available until September 2012 and even then, only sold in “certified pharmacies”. ) it is a combination of two different drugs: Phentermine - an appetite suppressant, and the “safer” “phen” part of the infamously unsafe fen-phen diet drug combo, and Topiramate - an anti seizure/migraine drug which increases feelings of fullness, making food taste less appealing, therefore increasing calorie burning.

Qsymia is not for everyone, it has serious side effects and is intended for women that are 5’4″ and weigh at least 174 pounds, and for men that are 5’9″ and weigh at least 203 pounds.

Serious side effects of Qsymia include:

Increased Heart Rate
Metabolic Acidosis
Birth Defects
Cardiovascular Risk
Cleft Lip
Cleft Palate

According to Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, “Qsymia, used responsibly in combination with a healthy lifestyle that includes a reduced-calorie diet and exercise, provides another treatment option for chronic weight management in Americans who are obese or are overweight and have at least one weight-related comorbid condition.”